Everything in nuclear medicine is supposed to decay with time. Somebody forgot to tell the field itself.

Dear hospital administrators: Your nuclear medicine department is not dying, it is being recruited. The good news is that the field is hot again. The bad news is that so are our technologists’ resumes. Not long ago, people assumed nuclear medicine was quietly fading out: programs were closing, graduates were dwindling, and a federal forecast showed the workforce shrinking. Then a cancer drug showed up and rewrote the script. I know how the story ends, because I am living it. My technologists keep getting offers I cannot match.

A Comeback Few Saw Coming

So what changed? Molecular imaging stopped merely photographing disease and started treating it. Radioligand therapy is a radioactive payload with a GPS that travels through the body, finds the tumor cells it was built for, and delivers the dose right where it is needed. In practice, that makes the technologist the person who prepares the radioactive drug, gives it to the patient, and keeps everyone in the room safe while doing it (U.S. Bureau of Labor Statistics [BLS], 2026). The role is part pharmacist, part imaging expert, part radiation safety officer, and the market has noticed.

The results have been hard to ignore. Pluvicto, the best known of these drugs, grew 42% in 2025, according to Novartis figures reported by Meticulous Research (2026). The FDA has also widened its prostate cancer label twice since March 2025 (Meticulous Research, 2026). When a drug label keeps getting bigger, the field that delivers it stops looking like a sunset industry.

Analysts see the wider nuclear medicine market climbing from $13.72 billion in 2026 to $55.75 billion by 2034 (Fortune Business Insights, 2026). Forecasts from paid research vendors vary wildly, so treat them as a weather report, not a contract. Even the federal forecast changed its mind. Technologist jobs were once projected to shrink; now they are projected to grow (BLS, 2026; Trout et al., 2025).

The people closest to the work saw it coming. In a 2022 survey of imaging sites, consisting of mostly European academic centers, respondents reported that PSMA PET and radioligand therapy volumes had grown 50% and 82% on average over the prior five years, and they expected another doubling (Beyer et al., 2023). The same survey listed staff availability among the biggest brakes on that growth.

A Growing Market Meets a Scarce Pipeline

Here’s the catch: Nobody built the training pipeline for a comeback. Accredited programs graduated 537 technologists in 2023, down 31% from 2011 (Trout et al., 2025), while BLS (2026) expects about 800 openings a year. Picture a restaurant that finally has a line out the door and discovers the culinary school down the street closed.

It gets stranger. Approved clinical training slots outnumber graduates by more than two to one, so the bottleneck is not only seats, and the researchers say the cause is undefined (Trout et al., 2025). Fifteen states have no accredited program at all. Nationally, the vacancy rate has eased from 14.5% in 2023 to 12.6% in 2025, which sounds like relief until you learn it is still above where it stood in 2020 (American Society of Radiologic Technologists [ASRT], 2025).

Which is why a technologist with the right skills can name a price. Here is what the market is offering.

Note. Data from U.S. Bureau of Labor Statistics (2026) and Trusted Health (n.d.). Travel pay annualized at 52 weeks.

Outpatient centers and travel agencies pay roughly 1.7 to 2 times what hospitals do (BLS, 2026; Trusted Health, n.d.). The travel data comes from the 10 highest-paying postings on one major board in October 2026, and annualizing assumes back-to-back contracts, so read them as what the market is bidding, not a salary anyone actually earns.

Even staff jobs are joining the arms race. One Illinois health system is dangling a $20,000 sign-on bonus (OSF HealthCare, 2026). That is not a perk. It is a confession about the market.

Then there are the travelers. They are not hard to find on a map: three of the five highest-paying postings on that board were in California (Trusted Health, n.d.). The weekly totals include stipends, so the picture is a little rosier than a paycheck, but nobody is mistaking it for a small number.

What Imaging Leaders Can Do to Stay Competitive

So what do we do? Six ideas, none of which involves wishing harder.

1. Pay like you mean it. Check your technologists against what travel and outpatient employers are offering and consider a premium for anyone certified to give radioligand therapy. Then price out retention pay for the people you have against the cost of agency coverage and empty positions, since competitors are paying $20,000 just to get someone through the door (OSF HealthCare, 2026).
2. Fill the chairs you already have. Accredited programs have more than twice as many approved clinical slots as graduates (Trout et al., 2025), which makes this a recruiting problem, not just a building problem. Sponsor students, pay for preceptor time, and tie tuition help to a service commitment.
3. Build a bridge from radiography and CT. A radiologic technology degree plus a 12-month nuclear medicine certificate is a recognized route into the field (BLS, 2026). A funded bridge turns people who already know your sites into the technologists you cannot find.
4. Take the classroom to the people. One university-led effort set up hybrid classes, local clinical partners, and in-person labs in New England and Colorado. Sites there reported shorter vacancies and steadier staffing (Gilmore, 2026). It is early, conference-abstract evidence, so promising rather than proven.
5. Share your stars. In my health system, we built a system-wide per diem float pool that cut premium agency reliance and steadied coverage across 12 imaging sites. Run therapy from hub sites and keep diagnostic PET at the spokes, and your scarcest skills stretch further.
6. Give people somewhere to go. Lead, theranostics coordinator, and educator roles with real pay steps let a technologist grow without leaving the bench. Where licensing allows, take scheduling and dose logistics off their plates.

None of these moves are glamorous, and none works alone. Higher pay buys you time, bridges and classrooms build a roster of qualified professionals, and float pools and hubs stretch the staffing resources you have. Together they turn a bidding war into a plan.

The comeback is real. The question is whether we can keep the people who make it possible. Start by measuring three things: how long theranostics jobs stay open, what agency coverage costs per therapy shift, and how far your pay sits from the nearest freestanding competitor. Nuclear medicine just proved it can come back from decay. Now it has to keep its people.

References

American Society of Radiologic Technologists. (2025, July 24). ASRT staffing and workplace survey shows vacancy rate increases near record highs, aligning with overall health care profession trends [News release]. https://www.asrt.org/news/article/2025/07/24/asrt-staffing-and-workplace-survey-shows-vacancy-rate-increases-near-record-highs-aligning-with-overall-health-care-profession-trends

Beyer, T., Czernin, J., Freudenberg, L., Giesel, F., Hacker, M., Hicks, R. J., & Krause, B. J. (2023). A 2022 international survey on the status of prostate cancer theranostics. Journal of Nuclear Medicine, 64(1), 47–53. https://doi.org/10.2967/jnumed.122.264298

Fortune Business Insights. (2026). Nuclear medicine market size, share & industry analysis, by type, by application, by end-user, and regional forecast, 2026–2034 (Report ID FBI101812). https://www.fortunebusinessinsights.com/industry-reports/nuclear-medicine-radiopharmaceuticals-market-101812

Gilmore, D. (2026). Extending clinical reach to areas with no accredited nuclear medicine technology programs [Meeting abstract 26153]. Journal of Nuclear Medicine, 67(Suppl. 1). https://jnm.snmjournals.org/content/67/supplement_1/26153

Meticulous Research. (2026). Radioligand therapy market: Global opportunity analysis and industry forecast to 2036 (Report No. MR-2150). https://www.meticulousresearch.com/product/radioligand-therapy-market-6833

OSF HealthCare. (2026, July 7). Nuclear medicine technologist [Job posting]. Greater Peoria, IL Job Board. https://jobs.peoria.org/companies/osf-healthcare-2/jobs/85440566-nuclear-medicine-technologist

Trout, A. T., Fisher, R., McCumiskey, J., & Winn, J. (2025). The nuclear medicine technologist education landscape according to the Joint Review Committee on Educational Programs in Nuclear Medicine Technology. Journal of Nuclear Medicine Technology, 53(3), 9A–10A. https://doi.org/10.2967/jnmt.125.270366

Trusted Health. (n.d.). Nuclear medicine travel nuclear medicine technologist jobs [Job listings]. Retrieved October 13, 2026, from https://www.trustedhealth.com/jobs/travel-allied/roles/nuclear-medicine-technologist/units/nuclear_medicine

U.S. Bureau of Labor Statistics. (2026, August 27). Nuclear medicine technologists. In Occupational outlook handbook. https://www.bls.gov/ooh/healthcare/nuclear-medicine-technologists.htm